Our findings implicating P‐cadherin as a tumor promoting molecule, and the prognostic value of CDH3 independent of other known prognostic indicators, suggest this cell–cell adhesion molecule may be an attractive new therapeutic target for P‐cadherin‐positive tumors. The gene discussed is CDH3; the disease is neoplasm.